These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 74269)

  • 41. Effect of cyproterone acetate in comparison to flutamide and megestrol acetate on the ventral prostate, seminal vesicle, and adrenal glands of adult male rats.
    el Etreby MF; Habenicht UF; Louton T; Nishino Y; Schröder HG
    Prostate; 1987; 11(4):361-75. PubMed ID: 2960960
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interaction of cyproterone acetate with rat prostatic androgen receptors.
    Traish AM; Muller RE; Wotiz HH
    Steroids; 1985; 45(3-4):247-62. PubMed ID: 2939604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Binding of chlormadinone acetate to cytosol from human benign prostatic hypertrophy.
    Kodama T; Wakisaka M; Shimazaki J
    Endocrinol Jpn; 1980 Feb; 27(1):53-7. PubMed ID: 6156069
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mode of spironolactone anti-androgenic action: inhibition of androstanolone binding to rat prostate androgen receptor.
    Bonne C; Raynaud JP
    Mol Cell Endocrinol; 1974 Dec; 2(1):59-67. PubMed ID: 4376096
    [No Abstract]   [Full Text] [Related]  

  • 45. Progestogens with antiandrogenic properties.
    Raudrant D; Rabe T
    Drugs; 2003; 63(5):463-92. PubMed ID: 12600226
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specific binding of androgen and androgen-receptor complex by microsomes from rat ventral prostate.
    Steinsapir J; Muldoon TG
    J Steroid Biochem Mol Biol; 1990 Dec; 37(5):697-705. PubMed ID: 2278853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of two different medical treatments on dihydrotestosterone content and androgen receptors in human benign prostatic hyperplasia.
    Petrangeli E; Sciarra F; Di Silverio F; Toscano V; Lubrano C; Conti C; Concolino G
    J Steroid Biochem; 1988; 30(1-6):395-9. PubMed ID: 2455099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Receptor binding and biological activity of steroidal and nonsteroidal antiandrogens.
    Wakeling AE; Furr BJ; Glen AT; Hughes LR
    J Steroid Biochem; 1981 Dec; 15():355-9. PubMed ID: 7339263
    [No Abstract]   [Full Text] [Related]  

  • 49. The synthetic androgen mibolerone induces transient suppression of the transformed phenotype in an androgen responsive human prostatic carcinoma cell line.
    Schulz P; Wolf D; Arbusow V; Bojar H; Klobeck HG; Fittler F
    Andrologia; 1990; 22 Suppl 1():56-66. PubMed ID: 2151880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Androgen receptor in rat skeletal muscle: characterization and physiological variations.
    Michel G; Baulieu EE
    Endocrinology; 1980 Dec; 107(6):2088-98. PubMed ID: 6968675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of estrogen receptor, androgen receptor and growth factors in diethylstilbestrol-induced programming of prostate differentiation.
    Gupta C
    Urol Res; 2000 Aug; 28(4):223-9. PubMed ID: 11011959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enzymatic and binding activities of 5 alpha-reductase and androgen receptors in hamster prostate.
    Cabeza M; Bratoeff E; Heuze I; Ramírez E; Sánchez M; Flores E
    Proc West Pharmacol Soc; 2003; 46():128-31. PubMed ID: 14699908
    [No Abstract]   [Full Text] [Related]  

  • 53. Differences in androgen-binding properties of the two molecular forms of androgen receptor in rat ventral prostate cytosol.
    Feit EI; Muldoon TG
    Endocrinology; 1983 Feb; 112(2):592-600. PubMed ID: 6848364
    [No Abstract]   [Full Text] [Related]  

  • 54. Antagonist action of dihydroprogesterone on the formation of the specific dihydrotestosterone-cytoplasmic receptor complex in rat ventral prostate.
    Wright F; Kirchhoffer MO; Mauvais-Jarvis P
    J Steroid Biochem; 1979 Apr; 10(4):419-22. PubMed ID: 449318
    [No Abstract]   [Full Text] [Related]  

  • 55. The effect of dihydrotestosterone on the estrogen-induced cytodifferentiation of the chick oviduct.
    Joensuu TK; Bläuer MK; Sannisto T; Tuohimaa PJ
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):701-9. PubMed ID: 1532905
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action.
    Furr BJ; Tucker H
    Urology; 1996 Jan; 47(1A Suppl):13-25; discussion 29-32. PubMed ID: 8560673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the receptor binding properties of nandrolone and testosterone under in vitro and in vivo conditions.
    Bergink EW; Janssen PS; Turpijn EW; van der Vies J
    J Steroid Biochem; 1985 Jun; 22(6):831-6. PubMed ID: 4021486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effects of various drugs on the formation of a complex of prostatic cytosol receptor protein and dihydrotestosterone].
    Yamanaka H; Yuasa H; Koya J; Imai K; Kitaura K
    Horumon To Rinsho; 1978 Jan; 26(1):89-92. PubMed ID: 688651
    [No Abstract]   [Full Text] [Related]  

  • 59. ICI 176,334: a novel non-steroidal, peripherally-selective antiandrogen.
    Furr BJ
    Prog Clin Biol Res; 1988; 260():13-26. PubMed ID: 2966405
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of the antiandrogenic/androgenic activities of flutamide, cyproterone acetate and megestrol acetate.
    Poyet P; Labrie F
    Mol Cell Endocrinol; 1985 Oct; 42(3):283-8. PubMed ID: 3930312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.